content: <html>
  
  <head>
  
  
  
  
  
  </head>
  
  <body lang="EN-US">
  
  <div style="font-family:Times New Roman;">
  
  <div style="border:none;border-top:double windowtext 6.0pt;padding:0in 0in 0in 0in;">
  
  <p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  </div>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED
  STATES</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES
  AND EXCHANGE COMMISSION</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WASHINGTON,
  DC 20549</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT
  REPORT</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">PURSUANT
  TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">SECURITIES
  EXCHANGE ACT OF 1934</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of report
  (Date of earliest event reported):<b>&nbsp;&nbsp;April&nbsp;29,
  2008 (April&nbsp;28, 2008)</b></font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">Momenta Pharmaceuticals,&nbsp;Inc.</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact Name of
  Registrant as Specified in its Charter)</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div align="center">
  
  <table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
   <tr>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-50797</font></b></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">04-3561634</font></b></p>
    </td>
   </tr>
   <tr>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or Other
    Jurisdiction<br>
    of Incorporation)</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File
    Number)</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(IRS Employer
    Identification<br>
    No.)</font></p>
    </td>
   </tr>
   <tr>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="66%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:66.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">675
    West Kendall Street, Cambridge, MA</font></b></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">02142</font></b></p>
    </td>
   </tr>
   <tr>
    <td width="66%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:66.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of
    Principal Executive Offices)</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip Code)</font></p>
    </td>
   </tr>
  </table>
  
  </div>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(617)
  491-9700</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s
  telephone number,<br>
  including area code)</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Not
  applicable</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former Name or
  Former Address, if Changed Since Last Report)</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K
  filing is intended to simultaneously satisfy the filing obligation of the
  registrant under any of the following provisions (<i>see</i> General Instruction A.2. below):</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written
  communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR
  230.425)</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting
  material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR
  240.14a-12)</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
  communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17
  CFR 240.14d-2(b))</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
  communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17
  CFR 240.13e-4(c))</p>
  
  <div style="border:none;border-bottom:double windowtext 6.0pt;padding:0in 0in 0in 0in;">
  
  <p style="border:none;margin:0in 0in .0001pt 1.0in;padding:0in;text-indent:-1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  </div>
  
  <p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  
  <table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
   <tr>
    <td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.08%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.02.</font></b></p>
    </td>
    <td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.92%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Departure of Directors or Certain Officers; Election of
    Directors; Appointment of Certain Officers; Compensatory Arrangements of
    Certain Officers.</font></b></p>
    </td>
   </tr>
  </table>
  
  <p style="margin:0in 0in .0001pt .8in;text-indent:-.8in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Termination of Executive Retention Agreements and Employment Agreement
  with Ganesh Venkataraman</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Executive Retention Agreements</font></i></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">On March&nbsp;14, 2007, </font>Momenta Pharmaceuticals,&nbsp;Inc.,
  a Delaware corporation (the &#147;Company&#148;), </font>entered into Executive Retention Agreements (the &#147;Retention
  Agreements&#148;) with the following executive officers of the Company:&#160; Richard P. Shea, Senior Vice President and
  Chief Financial Officer; Ganesh Venkataraman, Chief Scientific Officer, Senior
  Vice President, Research; Steven B. Brugger, Chief Operating Officer; and John
  E. Bishop, Senior Vice President, Pharmaceutical Sciences.</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the terms of the Retention Agreements, in the
  event an executive&#146;s employment was terminated without cause (as defined in the
  Retention Agreement) or the executive terminated his employment with good
  reason (as defined in the Retention Agreement) within one year following a
  change in control of the Company (as defined in the Retention Agreement), each
  executive was entitled to:</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <table border="0" cellspacing="0" cellpadding="0" width="94%" style="border-collapse:collapse;margin-left:27.35pt;width:94.1%;">
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">accrued
    obligations as of the date of such termination, consisting of accrued and
    unpaid salary, the value of accrued vacation days and the amount of
    unreimbursed and incurred expenses;</font></p>
    </td>
   </tr>
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">acceleration
    of each outstanding award then held by the executive under the Company&#146;s
    outstanding equity incentive plans;</font></p>
    </td>
   </tr>
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the sum
    of (1)&nbsp;the amount equal to the executive&#146;s annual base salary during the
    one year period prior to the date of termination and (2)&nbsp;the greater of
    (i)&nbsp;the target bonus for the executive for the fiscal year in which the
    termination occurred and (ii)&nbsp;the annual bonus paid to the executive for
    the most recently completed fiscal year; and</font></p>
    </td>
   </tr>
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font></p>
    </td>
    <td width="96%" valign="bottom" style="padding:0in 0in 0in 0in;width:96.66%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">insurance,
    medical, dental, health and accident and disability benefits as in effect
    immediately prior to the termination date for a period of 12 months.</font></p>
    </td>
   </tr>
  </table>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Retention Agreements automatically renewed for
  successive one year terms unless 90 days prior to the end of any calendar year,
  the Company provided written notice that the term would not be extended.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Employment Agreement with Ganesh
  Venkataraman</font></i></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company entered into an employment agreement with Ganesh
  Venkataraman dated June&nbsp;13, 2001, which was amended and restated on April&nbsp;10,
  2002 (the &#147;Venkataraman Employment Agreement&#148;).&#160;
  Pursuant to the Venkataraman Employment Agreement, Mr.&nbsp;Venkataraman
  received an annual base salary, subject to increases upon review at least once
  every 12 months.&#160; Under the Venkataraman
  Employment Agreement, either the Company or </font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Venkataraman could terminate his employment at any time,
  subject to continuation of salary payment and benefits for three months if the
  Company terminated Mr.&nbsp;Venkataraman&#146;s employment without cause or Mr.&nbsp;Venkataraman
  terminated his employment for good reason.&#160;
  Effective as of January&nbsp;1, 2008, the Company&#146;s compensation
  committee approved an increase in Mr.&nbsp;Venkataraman&#146;s salary for 2008 to
  $302,565, as well as a $92,660.58 bonus based on Mr.&nbsp;Venkataraman&#146;s and
  the Company&#146;s 2007 achievements, the grant of an option to purchase 34,750
  shares of the Company&#146;s common stock and an award of 5,000 shares of restricted
  common stock.&#160; The Venkataraman
  Employment Agreement also contained nondisclosure, noncompetition and
  assignment of intellectual property terms.&#160;
  These terms provided for the protection of the Company&#146;s confidential
  information, the transfer of ownership rights to intellectual property
  developed by Mr.&nbsp;Venkataraman and a 12-month noncompete provision.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with the execution of the Employment
  Agreements described below, each of the Retention Agreements and the
  Venkataraman Employment Agreement have been terminated.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Employment
  Agreements with each of Richard P. Shea, Ganesh Venkataraman, Steven B. Brugger
  and John E. Bishop</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;28, 2008,
  the Company entered into an Employment Agreement (the &#147;Employment Agreement&#148;)
  with each of Richard P. Shea, Ganesh Venkataraman, Steven B. Brugger and John
  E. Bishop.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Salary,
  Bonus and Benefits.&#160; </font></i>Pursuant
  to the Employment Agreements, Messrs.&nbsp;Shea, Brugger, Bishop and
  Venkataraman will receive annual base salaries of $280,800, $353,280, $283,379
  and $302,565, respectively, subject to adjustment thereafter, as determined by
  the Company&#146;s Board of Directors or a committee or designee thereof.&#160; If the Company&#146;s Board of Directors approves
  an annual bonus for calendar year 2008 or any calendar year thereafter, Messrs.&nbsp;Shea,
  Brugger, Bishop and Venkataraman will be eligible for a discretionary bonus
  award.&#160; The annual target for each executive&#146;s
  bonus will be 35%, 45%, 35% and 35% of the annualized base salary for Messrs.&nbsp;Shea,
  Brugger, Bishop and Venkataraman, respectively.&#160;
  The Company will determine, in its sole discretion, whether (and in what
  amount) a bonus award is payable to each executive.&#160; In determining whether a bonus award in any
  given year shall be granted, the Company will review whether it has achieved
  its annually approved corporate goals as well as whether the executive has
  achieved his personal objectives as established by the Company.&#160; In order to be eligible for any bonus
  hereunder, the executive must be an active employee of the Company on the date
  such bonus is distributed.</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each executive shall be
  entitled to participate in all benefit plans and programs that the Company
  establishes and makes available to its employees to the extent that the
  executive is eligible under (and subject to the provisions of) the plan
  documents governing those programs.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Payments
  Upon Resignation by the Executive Without Good Reason or Termination By the
  Company for Cause</font></i>.&#160; If
  the executive voluntarily resigns his employment other than for good reason (as
  defined in each Employment Agreement), or if the Company terminates the
  executive for cause (as defined in each Employment Agreement), the Company
  shall pay the executive all accrued and unpaid base salary through the
  executive&#146;s date of termination and any vacation that is accrued but unused as
  of such date.&#160; The executive shall not be
  eligible for any severance or </p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">separation payments or any continuation of benefits (other than those
  provided for under the Federal Consolidated Omnibus Budget Reconciliation Act (&#147;COBRA&#148;)),
  or any other compensation pursuant to the Employment Agreement or otherwise.&#160; The executive also shall have such rights, if
  any, with respect to outstanding stock options and restricted stock grants as
  may be provided under each applicable agreement.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Payments
  Upon Termination by Reason of Death or Disability, Termination Without Cause or
  Resignation for Good Reason</font></i>.&#160;
  If the executive&#146;s employment with the Company is terminated by reason
  of the executive&#146;s death or disability (as defined in each Employment
  Agreement), by the Company without cause, or by the executive&#146;s voluntary
  resignation for good reason, other than in connection with a change in control
  (as defined in each Employment Agreement), then the executive shall be paid all
  accrued and unpaid base salary and any accrued but unused vacation through the
  date of termination.&#160; In addition, if the
  executive&#146;s employment with the Company is terminated by reason of the
  executive&#146;s disability, by the Company without cause, or by the executive&#146;s
  voluntary resignation for good reason, subject to the executive&#146;s execution and
  non-revocation of a binding severance and mutual release agreement in a form
  provided by and satisfactory to the Company, the executive shall be eligible to
  receive the following separation benefits:</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>an amount equal to the sum
  of (1)&nbsp;12 months of the executive&#146;s base salary as of the date of
  termination (which amount shall be payable in installments in accordance with
  the Company&#146;s regular payroll practices, beginning on the next payroll date
  following the 30th day after the date of termination) and (2)&nbsp;the greater
  of (i)&nbsp;the annual discretionary target bonus established by the Company&#146;s
  Board of Directors (or any other person or persons having authority with
  respect thereto) for the executive for the fiscal year in which the date of
  termination occurs or (ii)&nbsp;the annual bonus paid to the executive for the
  most recently completed fiscal year (which amount shall be payable in one lump
  sum on the next payroll date following the 30th day after the date of
  termination);</p>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>if the executive is eligible
  for and elects to continue his medical and/or dental health insurance coverage
  pursuant to COBRA, the Company shall continue to contribute, until the earlier
  of (1)&nbsp;12 months following the date of termination or (2)&nbsp;the date on
  which the executive becomes eligible to receive group medical and/or dental
  insurance coverage through a new employer, toward the cost of the executive&#146;s
  COBRA premiums in the same amount that it pays on behalf of active and
  similarly situated employees receiving the same type of coverage;</p>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>the Company shall continue
  to provide benefits to the executive in accordance with any applicable life
  insurance, accident and/or disability plans under which the executive was
  eligible as of the date of termination consistent with such benefits as may be
  provided to active and similarly situated employees covered by such plans,
  until the earlier of (1)&nbsp;12 months following the date of termination or (2)&nbsp;the
  date on which the executive becomes eligible to receive substantially
  comparable coverage through a new employer; provided, however, that if such
  plans do not permit continued coverage of the executive following the date of
  termination, the Company shall instead reimburse the executive for the
  reasonable cost of purchasing substantially comparable coverage during such
  period; and</p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>the executive shall be entitled to continued vesting
  of any unvested stock options and any future stock option grants awarded
  to the executive after the date of the Employment Agreement for a period of 12
  months from the date of termination and the right to exercise any outstanding
  stock options shall terminate on the earlier of three months after such
  12-month period and the original expiration date of the applicable outstanding
  stock option.&#160; The executive shall also
  be entitled to immediate vesting, on the date of termination, of any restricted
  stock awards with underlying shares that vest solely through the passage of
  time (i.e., service-based vesting) and not upon the achievement of specified
  conditions or milestones (i.e., performance-based vesting), including any
  future restricted stock awards granted to the executive after the date of the
  Employment Agreement that contain service-based vesting provisions, in each case
  that would have vested during the period of 12 months from the date of
  termination.</p>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Payments
  Upon Termination in Connection with a Change of Control</font></i>.&#160; If the executive&#146;s employment with the
  Company is terminated without cause or if the executive terminates his
  employment with good reason within one year following a change in control (as
  defined in each Employment Agreement), the executive shall be entitled to all
  accrued and unpaid base salary and any accrued but unused vacation through the
  date of termination.&#160; In addition, the
  executive shall be eligible to receive the following separation benefits:</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>an amount equal to the sum
  of (1)&nbsp;12 months of the executive&#146;s base salary as of the date of
  termination (which amount shall be payable in one lump sum on the next payroll
  date following the 30th day after the date of termination) and (2)&nbsp;the
  greater of (i)&nbsp;the annual discretionary target bonus established by the
  Company&#146;s Board of Directors (or any other person or persons having authority
  with respect thereto) for the executive for the fiscal year in which the date
  of termination occurs or (ii)&nbsp;the annual bonus paid to the executive for
  the most recently completed fiscal year (which amount shall be payable in one
  lump sum on the next payroll date following the 30th day after the date of
  termination);</p>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>if the executive is eligible
  for and elects to continue his medical and/or dental health insurance coverage
  pursuant to COBRA, the Company shall continue to contribute, until the earlier
  of (1)&nbsp;12 months following the date of termination or (2)&nbsp;the date on
  which the executive becomes eligible to receive group medical and/or dental
  insurance coverage through a new employer, toward the cost of the executive&#146;s
  COBRA premiums in the same amount that it pays on behalf of active and
  similarly situated employees receiving the same type of coverage;</p>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>the Company shall continue
  to provide benefits to the executive in accordance with any applicable life
  insurance, accident and/or disability plans under which the executive was
  eligible as of the date of termination consistent with such benefits as may be
  provided to active and similarly situated employees covered by such plans,
  until the earlier of (1)&nbsp;12 months following the date of termination or (2)&nbsp;the
  date on which the executive becomes eligible to receive substantially
  comparable coverage through a new employer; provided, however, that if such
  plans do not permit continued coverage of the executive following the date of
  termination, the Company shall instead reimburse the executive for the
  reasonable cost of purchasing substantially comparable coverage during such
  period; and</p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>the executive shall be
  entitled to immediate vesting of any unvested stock options, restricted stock
  awards and any future grants awarded to the executive.&#160; All such equity awards (whether stock options
  or restricted stock grants) will remain exercisable in accordance with the
  applicable stock option plan or grant agreement.</p>
  
  <p style="margin:0in 0in .0001pt 45.35pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Non-Competition,
  Non-Solicitation, Confidential Information and Developments</font></i>.&#160; In connection with the execution of the
  Employment Agreements, Messrs.&nbsp;Bishop, Brugger and Shea restated and
  reaffirmed all of their respective obligations pursuant to their respective
  Company Employee Non-disclosure, Non-competition and Assignment of Inventions
  Agreement providing for the protection of the Company&#146;s confidential
  information, the transfer of ownership rights to intellectual property
  developed by each such executive and a 12-month noncompete provision.&#160; Mr.&nbsp;Venkataraman&#146;s Employment Agreement
  contains provisions for the protection of the Company&#146;s confidential
  information, the transfer of ownership rights to intellectual property
  developed by him and a 12-month noncompete provision.</p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The form of Employment
  Agreement will be filed as an exhibit to the Company&#146;s Quarterly Report on Form&nbsp;10-Q
  for the Quarter ended March&nbsp;31, 2008.</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURE</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the
  Securities Exchange Act of 1934, the Registrant has duly caused this report to
  be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
   <tr>
    <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MOMENTA
    PHARMACEUTICALS, INC.</font></b></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: April&nbsp;29, 2008</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
    </td>
    <td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Richard P. Shea</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
    <p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">&nbsp;Richard P. Shea</font><br>
    &nbsp;</font>Chief Financial Officer<br>
    &nbsp;(Principal Financial Officer)</p>
    </td>
   </tr>
  </table>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\rmoralec\08-12814-1\task2902666\12814-1-ba.htm',USER='rmoralec',CD='Apr 29 13:04 2008' -->
  
  
  </body>
  
  </html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "a08-12814_18k.htm", "description": "8-K", "secsgml_size_bytes": 48597}]
metadata_filer: {"company-data": {"conformed-name": "MOMENTA PHARMACEUTICALS INC", "cik": "0001235010", "assigned-sic": "2836", "irs-number": "043561634", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-50797", "film-number": "08784394"}, "business-address": {"street1": "675 WEST KENDALL STREET", "city": "CAMBRIDGE", "state": "MA", "zip": "02142", "phone": "617 491-9700"}, "mail-address": {"street1": "675 WEST KENDALL STREET", "city": "CAMBRIDGE", "state": "MA", "zip": "02142"}}
text: UNITED
  STATES
  SECURITIES
  AND EXCHANGE COMMISSION
  WASHINGTON,
  DC 20549
  FORM 8-K
  CURRENT
  REPORT
  PURSUANT
  TO SECTION 13 OR 15(d) OF THE
  SECURITIES
  EXCHANGE ACT OF 1934
  Date of report
  (Date of earliest event reported):
  April 29,
  2008 (April 28, 2008)
  Momenta Pharmaceuticals, Inc.
  (Exact Name of
  Registrant as Specified in its Charter)
  Delaware
  000-50797
  04-3561634
  (State or Other
    Jurisdiction
  of Incorporation)
  (Commission File
    Number)
  (IRS Employer
    Identification
  No.)
  675
    West Kendall Street, Cambridge, MA
  02142
  (Address of
    Principal Executive Offices)
  (Zip Code)
  (617)
  491-9700
  (Registrant's
  telephone number,
  including area code)
  Not
  applicable
  (Former Name or
  Former Address, if Changed Since Last Report)
  Check the appropriate box below if the Form 8-K
  filing is intended to simultaneously satisfy the filing obligation of the
  registrant under any of the following provisions (
  see
  General Instruction A.2. below):
  o
  Written
  communications pursuant to Rule 425 under the Securities Act (17 CFR
  230.425)
  o
  Soliciting
  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
  240.14a-12)
  o
  Pre-commencement
  communications pursuant to Rule 14d-2(b) under the Exchange Act (17
  CFR 240.14d-2(b))
  o
  Pre-commencement
  communications pursuant to Rule 13e-4(c) under the Exchange Act (17
  CFR 240.13e-4(c))
  Item 5.02.
  Departure of Directors or Certain Officers; Election of
    Directors; Appointment of Certain Officers; Compensatory Arrangements of
    Certain Officers.
  (e)
  Termination of Executive Retention Agreements and Employment Agreement
  with Ganesh Venkataraman
  Executive Retention Agreements
  On March 14, 2007,
  Momenta Pharmaceuticals, Inc.,
  a Delaware corporation (the "Company"),
  entered into Executive Retention Agreements (the "Retention
  Agreements") with the following executive officers of the Company:  Richard P. Shea, Senior Vice President and
  Chief Financial Officer; Ganesh Venkataraman, Chief Scientific Officer, Senior
  Vice President, Research; Steven B. Brugger, Chief Operating Officer; and John
  E. Bishop, Senior Vice President, Pharmaceutical Sciences.
  Pursuant to the terms of the Retention Agreements, in the
  event an executive's employment was terminated without cause (as defined in the
  Retention Agreement) or the executive terminated his employment with good
  reason (as defined in the Retention Agreement) within one year following a
  change in control of the Company (as defined in the Retention Agreement), each
  executive was entitled to:
  ·
  accrued
    obligations as of the date of such termination, consisting of accrued and
    unpaid salary, the value of accrued vacation days and the amount of
    unreimbursed and incurred expenses;
  ·
  acceleration
    of each outstanding award then held by the executive under the Company's
    outstanding equity incentive plans;
  ·
  the sum
    of (1) the amount equal to the executive's annual base salary during the
    one year period prior to the date of termination and (2) the greater of
    (i) the target bonus for the executive for the fiscal year in which the
    termination occurred and (ii) the annual bonus paid to the executive for
    the most recently completed fiscal year; and
  ·
  insurance,
    medical, dental, health and accident and disability benefits as in effect
    immediately prior to the termination date for a period of 12 months.
  The Retention Agreements automatically renewed for
  successive one year terms unless 90 days prior to the end of any calendar year,
  the Company provided written notice that the term would not be extended.
  Employment Agreement with Ganesh
  Venkataraman
  The Company entered into an employment agreement with Ganesh
  Venkataraman dated June 13, 2001, which was amended and restated on April 10,
  2002 (the "Venkataraman Employment Agreement"). 
  Pursuant to the Venkataraman Employment Agreement, Mr. Venkataraman
  received an annual base salary, subject to increases upon review at least once
  every 12 months.  Under the Venkataraman
  Employment Agreement, either the Company or
  2
  Mr. Venkataraman could terminate his employment at any time,
  subject to continuation of salary payment and benefits for three months if the
  Company terminated Mr. Venkataraman's employment without cause or Mr. Venkataraman
  terminated his employment for good reason. 
  Effective as of January 1, 2008, the Company's compensation
  committee approved an increase in Mr. Venkataraman's salary for 2008 to
  $302,565, as well as a $92,660.58 bonus based on Mr. Venkataraman's and
  the Company's 2007 achievements, the grant of an option to purchase 34,750
  shares of the Company's common stock and an award of 5,000 shares of restricted
  common stock.  The Venkataraman
  Employment Agreement also contained nondisclosure, noncompetition and
  assignment of intellectual property terms. 
  These terms provided for the protection of the Company's confidential
  information, the transfer of ownership rights to intellectual property
  developed by Mr. Venkataraman and a 12-month noncompete provision.
  In connection with the execution of the Employment
  Agreements described below, each of the Retention Agreements and the
  Venkataraman Employment Agreement have been terminated.
  Employment
  Agreements with each of Richard P. Shea, Ganesh Venkataraman, Steven B. Brugger
  and John E. Bishop
  On April 28, 2008,
  the Company entered into an Employment Agreement (the "Employment Agreement")
  with each of Richard P. Shea, Ganesh Venkataraman, Steven B. Brugger and John
  E. Bishop.
  Salary,
  Bonus and Benefits.
  Pursuant
  to the Employment Agreements, Messrs. Shea, Brugger, Bishop and
  Venkataraman will receive annual base salaries of $280,800, $353,280, $283,379
  and $302,565, respectively, subject to adjustment thereafter, as determined by
  the Company's Board of Directors or a committee or designee thereof.  If the Company's Board of Directors approves
  an annual bonus for calendar year 2008 or any calendar year thereafter, Messrs. Shea,
  Brugger, Bishop and Venkataraman will be eligible for a discretionary bonus
  award.  The annual target for each executive's
  bonus will be 35%, 45%, 35% and 35% of the annualized base salary for Messrs. Shea,
  Brugger, Bishop and Venkataraman, respectively. 
  The Company will determine, in its sole discretion, whether (and in what
  amount) a bonus award is payable to each executive.  In determining whether a bonus award in any
  given year shall be granted, the Company will review whether it has achieved
  its annually approved corporate goals as well as whether the executive has
  achieved his personal objectives as established by the Company.  In order to be eligible for any bonus
  hereunder, the executive must be an active employee of the Company on the date
  such bonus is distributed.
  Each executive shall be
  entitled to participate in all benefit plans and programs that the Company
  establishes and makes available to its employees to the extent that the
  executive is eligible under (and subject to the provisions of) the plan
  documents governing those programs.
  Payments
  Upon Resignation by the Executive Without Good Reason or Termination By the
  Company for Cause
  .  If
  the executive voluntarily resigns his employment other than for good reason (as
  defined in each Employment Agreement), or if the Company terminates the
  executive for cause (as defined in each Employment Agreement), the Company
  shall pay the executive all accrued and unpaid base salary through the
  executive's date of termination and any vacation that is accrued but unused as
  of such date.  The executive shall not be
  eligible for any severance or
  3
  separation payments or any continuation of benefits (other than those
  provided for under the Federal Consolidated Omnibus Budget Reconciliation Act ("COBRA")),
  or any other compensation pursuant to the Employment Agreement or otherwise.  The executive also shall have such rights, if
  any, with respect to outstanding stock options and restricted stock grants as
  may be provided under each applicable agreement.
  Payments
  Upon Termination by Reason of Death or Disability, Termination Without Cause or
  Resignation for Good Reason
  . 
  If the executive's employment with the Company is terminated by reason
  of the executive's death or disability (as defined in each Employment
  Agreement), by the Company without cause, or by the executive's voluntary
  resignation for good reason, other than in connection with a change in control
  (as defined in each Employment Agreement), then the executive shall be paid all
  accrued and unpaid base salary and any accrued but unused vacation through the
  date of termination.  In addition, if the
  executive's employment with the Company is terminated by reason of the
  executive's disability, by the Company without cause, or by the executive's
  voluntary resignation for good reason, subject to the executive's execution and
  non-revocation of a binding severance and mutual release agreement in a form
  provided by and satisfactory to the Company, the executive shall be eligible to
  receive the following separation benefits:
  ·
  an amount equal to the sum
  of (1) 12 months of the executive's base salary as of the date of
  termination (which amount shall be payable in installments in accordance with
  the Company's regular payroll practices, beginning on the next payroll date
  following the 30th day after the date of termination) and (2) the greater
  of (i) the annual discretionary target bonus established by the Company's
  Board of Directors (or any other person or persons having authority with
  respect thereto) for the executive for the fiscal year in which the date of
  termination occurs or (ii) the annual bonus paid to the executive for the
  most recently completed fiscal year (which amount shall be payable in one lump
  sum on the next payroll date following the 30th day after the date of
  termination);
  ·
  if the executive is eligible
  for and elects to continue his medical and/or dental health insurance coverage
  pursuant to COBRA, the Company shall continue to contribute, until the earlier
  of (1) 12 months following the date of termination or (2) the date on
  which the executive becomes eligible to receive group medical and/or dental
  insurance coverage through a new employer, toward the cost of the executive's
  COBRA premiums in the same amount that it pays on behalf of active and
  similarly situated employees receiving the same type of coverage;
  ·
  the Company shall continue
  to provide benefits to the executive in accordance with any applicable life
  insurance, accident and/or disability plans under which the executive was
  eligible as of the date of termination consistent with such benefits as may be
  provided to active and similarly situated employees covered by such plans,
  until the earlier of (1) 12 months following the date of termination or (2) the
  date on which the executive becomes eligible to receive substantially
  comparable coverage through a new employer; provided, however, that if such
  plans do not permit continued coverage of the executive following the date of
  termination, the Company shall instead reimburse the executive for the
  reasonable cost of purchasing substantially comparable coverage during such
  period; and
  4
  ·
  the executive shall be entitled to continued vesting
  of any unvested stock options and any future stock option grants awarded
  to the executive after the date of the Employment Agreement for a period of 12
  months from the date of termination and the right to exercise any outstanding
  stock options shall terminate on the earlier of three months after such
  12-month period and the original expiration date of the applicable outstanding
  stock option.  The executive shall also
  be entitled to immediate vesting, on the date of termination, of any restricted
  stock awards with underlying shares that vest solely through the passage of
  time (i.e., service-based vesting) and not upon the achievement of specified
  conditions or milestones (i.e., performance-based vesting), including any
  future restricted stock awards granted to the executive after the date of the
  Employment Agreement that contain service-based vesting provisions, in each case
  that would have vested during the period of 12 months from the date of
  termination.
  Payments
  Upon Termination in Connection with a Change of Control
  .  If the executive's employment with the
  Company is terminated without cause or if the executive terminates his
  employment with good reason within one year following a change in control (as
  defined in each Employment Agreement), the executive shall be entitled to all
  accrued and unpaid base salary and any accrued but unused vacation through the
  date of termination.  In addition, the
  executive shall be eligible to receive the following separation benefits:
  ·
  an amount equal to the sum
  of (1) 12 months of the executive's base salary as of the date of
  termination (which amount shall be payable in one lump sum on the next payroll
  date following the 30th day after the date of termination) and (2) the
  greater of (i) the annual discretionary target bonus established by the
  Company's Board of Directors (or any other person or persons having authority
  with respect thereto) for the executive for the fiscal year in which the date
  of termination occurs or (ii) the annual bonus paid to the executive for
  the most recently completed fiscal year (which amount shall be payable in one
  lump sum on the next payroll date following the 30th day after the date of
  termination);
  ·
  if the executive is eligible
  for and elects to continue his medical and/or dental health insurance coverage
  pursuant to COBRA, the Company shall continue to contribute, until the earlier
  of (1) 12 months following the date of termination or (2) the date on
  which the executive becomes eligible to receive group medical and/or dental
  insurance coverage through a new employer, toward the cost of the executive's
  COBRA premiums in the same amount that it pays on behalf of active and
  similarly situated employees receiving the same type of coverage;
  ·
  the Company shall continue
  to provide benefits to the executive in accordance with any applicable life
  insurance, accident and/or disability plans under which the executive was
  eligible as of the date of termination consistent with such benefits as may be
  provided to active and similarly situated employees covered by such plans,
  until the earlier of (1) 12 months following the date of termination or (2) the
  date on which the executive becomes eligible to receive substantially
  comparable coverage through a new employer; provided, however, that if such
  plans do not permit continued coverage of the executive following the date of
  termination, the Company shall instead reimburse the executive for the
  reasonable cost of purchasing substantially comparable coverage during such
  period; and
  5
  ·
  the executive shall be
  entitled to immediate vesting of any unvested stock options, restricted stock
  awards and any future grants awarded to the executive.  All such equity awards (whether stock options
  or restricted stock grants) will remain exercisable in accordance with the
  applicable stock option plan or grant agreement.
  Non-Competition,
  Non-Solicitation, Confidential Information and Developments
  .  In connection with the execution of the
  Employment Agreements, Messrs. Bishop, Brugger and Shea restated and
  reaffirmed all of their respective obligations pursuant to their respective
  Company Employee Non-disclosure, Non-competition and Assignment of Inventions
  Agreement providing for the protection of the Company's confidential
  information, the transfer of ownership rights to intellectual property
  developed by each such executive and a 12-month noncompete provision.  Mr. Venkataraman's Employment Agreement
  contains provisions for the protection of the Company's confidential
  information, the transfer of ownership rights to intellectual property
  developed by him and a 12-month noncompete provision.
  The form of Employment
  Agreement will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q
  for the Quarter ended March 31, 2008.
  6
  SIGNATURE
  Pursuant to the requirements of the
  Securities Exchange Act of 1934, the Registrant has duly caused this report to
  be signed on its behalf by the undersigned hereunto duly authorized.
  MOMENTA
    PHARMACEUTICALS, INC.
  Date: April 29, 2008
  By:
  /s/ Richard P. Shea
  Richard P. Shea
  Chief Financial Officer
  (Principal Financial Officer)
  7